β2肾上腺素能受体激动剂通过重建T细胞分化稳态纠正免疫性血小板减少症
该研究在小鼠免疫性血小板减少症(ITP)模型中,用6-羟基多巴胺进行化学性交感神经切除,观察到脾脏交感神经支配减少伴随Th1、Tc1细胞比例升高和调节性T细胞(Treg)比例降低,β2肾上腺素能受体(β2-AR)激动剂可恢复Treg比例并在第7天和第14天提高ITP小鼠血小板计数,提示β2-AR激动剂可能作为ITP的新型治疗。
要点
- ITP小鼠脾脏交感神经支配减少。
- 化学性交感神经切除的ITP小鼠Th1、Tc1细胞比例升高、Treg比例降低。
- β2-AR激动剂恢复ITP小鼠Treg比例并在第7天和第14天提高血小板计数。
核心结论
- 脾脏交感神经分布减少通过扰乱T细胞稳态参与ITP发病,β2-AR激动剂有潜力作为ITP的新型治疗。
研究设计与样本
- 在ITP小鼠模型中以6-羟基多巴胺进行化学性交感神经切除,并用β2-AR激动剂处理以评估交感神经去除和激活的效果。
主要发现
- 观察到ITP小鼠脾脏交感神经支配减少。
- 与未行交感神经切除的对照小鼠相比,化学性交感神经切除的ITP小鼠(ITP-syx小鼠)Th1和Tc1细胞百分比显著升高、Treg百分比降低。
- 与对照相比,ITP-syx小鼠Th1相关基因IFN-γ和IRF8表达显著上调,Treg相关基因Foxp3和CTLA4表达显著下调。
- β2-AR恢复ITP小鼠Treg百分比,并在第7天和第14天提高血小板计数。
临床怎么用
- 原文结论提示β2-AR激动剂有潜力作为ITP的新型治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The sympathetic nerve is known to regulate immune responses in autoimmunity. Aberrant T cell immunity plays a vital role in immune thrombocytopenia (ITP) pathogenesis. The spleen is the primary site of platelet destruction. However, little is known whether and how splenic sympathetic innervation and neuroimmune modulation contribute to ITP pathogenesis. OBJECTIVES: To determine the sympathetic distribution in the spleen of ITP mice and the association between splenic sympathetic nerves and T cell immunity in ITP development, and to evaluate the treatment potential of β2-adrenergic receptor (β2-AR) in ITP. METHODS: Chemical sympathectomy was performed in an ITP mouse model with 6-hydroxydopamine and treated with β2-AR agonists to evaluate the effects of sympathetic denervation and activation. RESULTS: Decreased sympathetic innervation in the spleen of ITP mice was observed. Significantly increased percentages of Th1 and Tc1 cells and reduced percentages of regulatory T cells (Tregs) were also observed in ITP mice with chemical sympathectomy (ITP-syx mice) relative to mice without sympathectomy (controls). Expression of genes associated with Th1, including IFN-γ and IRF8, was significantly upregulated, whereas genes associated with Tregs, including Foxp3 and CTLA4, were significantly downregulated in ITP-syx mice compared with controls. Furthermore, β2-AR restored the percentage of Tregs and increased platelet counts at days 7 and 14 in ITP mice. CONCLUSION: Our findings indicate that decreased sympathetic distribution contributes to ITP pathogenesis by disturbing the homeostasis of T cells and that β2-AR agonists have potential as a novel treatment for ITP.
引用
- Zhang GC, Wu YJ, Liu FQ, et al. β2-adrenergic receptor agonist corrects immune thrombocytopenia by reestablishing the homeostasis of T cell differentiation. J Thromb Haemost. 2023. PMID: 36972787. doi:10.1016/j.jtha.2023.02.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。